Kiora's Brian Strem shares early thoughts about retinal drug's commercial positioning - MM+M
Kiora Pharma’s Brian Strem shares early thoughts about the commercial positioning of lead asset KIO-301 with Jack O’Brien, plus policy updates and our Trends segment.
Source: mmm-online.com